Immunostimulation and immunoinhibition of premalignant lesions

Theoretical Biology and Medical Modelling

Volumn 4, Issue , 2007, Pages

  Prehn, Richmond T ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; CANCER INHIBITION; CELL INFILTRATION; COLORECTAL CANCER; GROWTH INHIBITION; GROWTH STIMULATION; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; MELANOMA; NONHUMAN; PROGNOSIS; REVIEW; SKIN PAPILLOMA; TUMOR CELL; TUMOR GROWTH; ANIMAL; COLORECTAL TUMOR; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MOUSE; PAPILLOMA; PRECANCER; SKIN TUMOR;

ANIMALS; COLORECTAL NEOPLASMS; HUMANS; IMMUNE TOLERANCE; IMMUNIZATION; MELANOMA; MICE; PAPILLOMA; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 33846997575     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-4-6     Document Type: Review

References (25)

1. Immunological enhancement and inhibition of tumor growth: relationship to various immunological mechanisms. N Kaliss, Federation Proc 1965 24 1024 1029
2. The immune reaction as a stimulator of tumor growth. RT Prehn, Science 1972 176 170 171 10.1126/science.176.4031.170 5014438
3. Immunostimulation of highly immunogenic target tumor cells by lymphoid cells in vitro. LM Prehn, J Natl Cancer Inst 1976 56 833 838 1255801
4. Failure of immunosurveillance against chemically induced in situ tumors in mice. EJ Andrews, J Natl Cancer Inst 1974 52 729 732 4826561
5. Immunodepression and malignancy. O Stutman, Adv Cancer Res 1975 22 261 422 766581
6. Tumor progression and homeostasis. RT Prehn, Adv Cancer Res 1976 23 203 236 775933
7. An adaptive immune reaction may be necessary for cancer development. RT Prehn, Theor Biol Med Model 2006 3 6 16457723 10.1186/1742-4682-3-6
8. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. BG Kim C Li W Qiao M Mamura B Kasprzak M Anver L Wolfraim S Hong E Mushinski M Potter SJ Kim XY Fu C Deng JJ Letterio, Nature 2006 441 1015 1019 10.1038/nature04846 16791201
9. Evidence for the antigenicity of papillomas induced by 3-methylcholanthrene. MA Lappé J Natl Cancer Inst 1968 40 823 846 4869135
10. Immunologic surveillance at the macroscopic level: nonselective elimination of premalignant skin papillomas. MA Lappé RT Prehn, Cancer Res 1969 29 2374 2378 5369684
11. Evidence of the nonimmune regression of chemically induced papillomas in mouse skin. EJ Andrews, J Natl Cancer Inst 1971 47 653 665 4945592
12. Tumor progression by lung cancers growing in hosts of different immunocompetence. WG Hammond JR Benfeld H Tesluk JR Johnson RL Teplitz, Cancer J 1995 8 130 138
13. Stimulation of liver regeneration and compensatory kidney hyperplasia by passive transfer of spleen cells. ME Pliskin RT Prehn, J Reticuloendothel Soc 1975 17 290 299 1151944
14. Melanomas in renal transplant recipients. L Le Mire K Hollowood D Gray C Bordea F Wojnarowska, Brit J Dermatol 2006 154 472 477 10.1111/j.1365-2133.2005. 07094.x
15. Excess melanocytic nevi in children with renal allografts. CH Smith JM McGregor JN Barker RW Morris SP Rigdon DM MacDonald, J Am Acad Dermatol 1993 28 51 55 8425970
16. Excess of nevi related to immunodeficiency: a study in HIV-infected patients and renal transplant recipients. JJ Grob S Bastuji-Garin L Vaillant JC Roujeau P Bernard B Sassolas C Guillaume, Journal of Investigative Dermatology 1996 107 694 697 10.1111/1523-1747.ep12365586 8875951
17. Immunohistological characterization of tumor infiltrating lymphocytes in melanocytic skin lesions. MB Hussein DA Elsers SA Fadel AE Omar, J Clin Pathol 2006 59 316 324 10.1136/jcp.2005.028860 16505286
18. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. CG Clemente MC Mihm Jr R Bufalino S Zumda P Collini N cascinelli, Cancer 1996 77 1303 1310 10.1002/(SICI)1097- 0142(19960401)77:7<1303::AID-CNCR123.0.CO;2-5 8608507
19. Melanocytes are potential immunocompetent cells: evidence from recognition of immunological characteristics of cultured human melanocytes. Y Lu WY Zhu C Tan GH Yu JX Gu, Pigment Cell Res 2002 15 454 460 10.1034/j.1600-0749. 2002.02065.x 12453188
20. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. J Galon A Costes F Sanchez-Cabo A Kirilovsky B Mlecik C Lagorce-Pagès M Tosolini M Camus A Berger P Wind F Zinzindohoué P Bruneval P-H Cunenc Z Trajanoski W-H Fridman F Pagès, Science 2006 313 1960 1964 10.1126/science.1129139 17008531
21. Reduced incidence of rectal cancer, compared to gastric and colonic cancer. THM Stewart, Clin Cancer Res 1997 3 51 55 9815537
22. Distribution of intestine-associated lymphoid tissue, aberrant crypt foci, and tumors of the large bowel of 1,2-dimethylhydrazine-treated mice. JW Carter HK Lancaster WE Hardman IL Cameron, Cancer Res 1994 54 4304 4307 8044776
23. Bartel's "Tonsille des Mastdarmes" und ihre stellung in der pathologie des lymphatischen apparates des mastdarme. H Steindl, Zentralblat fur Chirurgi 1935 62 2594 2601
24. Immunity to methylcholanthrene-induced sarcomas. RT Prehn JM Main, J Natl Cancer Inst 1957 18 769 778 13502695
25. What keeps cells in tissues behaving normally in the face of myriad mutations? H Rubin, BioEssays 2006 28 515 524 10.1002/bies.20403 16615084